Browsing Category
CBD
Combining the potential of 3D printed buccal films and nanostructured lipid carriers for…
Abstract
Cannabidiol (CBD) has been recognized for its numerous therapeutic benefits, such as neuroprotection, anti-inflammatory effects, and cardioprotection. However, CBD has some limitations, including unpredictable pharmacokinetics and low oral bioavailability. To overcome the challenges…
Read More...
Read More...
Feasibility study of the use of a homemade direct powder extrusion printer to manufacture printed…
Among the various 3D printing techniques, FDM is the most studied in pharmaceutical research. However, it requires the fabrication of filaments with suitable mechanical properties using HME, which can be laborious and time-consuming. DPE has emerged as a single-step printing technique that can…
Read More...
Read More...
Permeation-Enhancing Strategies for Transdermal Delivery of Cannabinoids
Introduction:
This review aims to provide an overview of the advancements and status of clinical studies and potential permeation-enhancing strategies in the transdermal delivery of cannabinoids.
Methods:
A systematic and comprehensive literature search across academic databases, search…
Read More...
Read More...
Cannabidiol safety considerations: Development of a potential acceptable daily intake value and…
Consumer use of hemp-derived products continues to rise, underscoring the need to establish evidence-based safety guidance. The present study sought to develop recommendations for oral upper intake limits of cannabidiol (CBD) isolate. Sufficiently robust and reliable data for this purpose were…
Read More...
Read More...
Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability…
Cannabinoids: cannabidiol (CBD), cannabidiolic acid (CBDA), and cannabichromene (CBC) are lipophilic compounds with limited water solubility, resulting in challenges related to their bioavailability and therapeutic efficacy upon oral administration. To overcome these limitations, we developed…
Read More...
Read More...
Formulation and quality consideration of cannabidiol printed forms produced by fused-deposition…
Introduction
Cannabidiol (CBD) is a promising non-psychoactive cannabinoid that shows several clinical outcomes. Commercially, this molecule is used in Epidiolex® (Greenwich Biosciences, Inc), a Food and Drug Administration (FDA)-approved drug to treat Lennox-Gastaut and Dravet syndromes,…
Read More...
Read More...
Advanced multifunctional nano-lipid carrier loaded gel for targeted delivery of 5-flurouracil and…
Non-melanoma skin cancer is one of the most common malignancies reported around the globe. Current treatment therapies fail to meet the desired therapeutic efficacy due to high degree of drug resistance. Thus, there is prominent demand in advancing the current conventional therapy to achieve desired…
Read More...
Read More...
Cannabinoid-Based Ocular Therapies and Formulations
The interest in the pharmacological applications of cannabinoids is largely increasing in a wide range of medical areas. Recently, research on its potential role in eye conditions, many of which are chronic and/or disabling and in need of new alternative treatments, has intensified. However, due to…
Read More...
Read More...
Oral lipid-based formulations alter delivery of cannabidiol to different anatomical regions in the…
Delivery to the brain is a challenging task due to its protection by the blood-brain barrier (BBB). Lipids and fatty acids are reported to affect the permeability of the BBB, although this has not been reported following oral administration. Cannabidiol (CBD) has high therapeutic potential in the…
Read More...
Read More...
FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for…
Given the growing cannabidiol (CBD) products market, the U.S. Food and Drug Administration convened a high-level internal working group to explore potential regulatory pathways for CBD products. Today we are announcing that after careful review, the FDA has concluded that a new regulatory pathway…
Read More...
Read More...